These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9050282)

  • 1. [Genetic cardiovascular risk factors].
    García Fuentes M; González-Lamuño D; Lozano MJ
    An Esp Pediatr; 1997 Jan; 46(1):3-7. PubMed ID: 9050282
    [No Abstract]   [Full Text] [Related]  

  • 2. The low down on lipoprotein lipase.
    Funke H; Assmann G
    Nat Genet; 1995 May; 10(1):6-7. PubMed ID: 7647792
    [No Abstract]   [Full Text] [Related]  

  • 3. [HDL and arteriosclerosis].
    Yamashita S; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1806-12. PubMed ID: 1479222
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of genetic risk for dyslipidemia.
    Yamada Y; Matsuo H; Warita S; Watanabe S; Kato K; Oguri M; Yokoi K; Metoki N; Yoshida H; Satoh K; Ichihara S; Aoyagi Y; Yasunaga A; Park H; Tanaka M; Nozawa Y
    Genomics; 2007 Nov; 90(5):551-8. PubMed ID: 17919884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus complicated with hyperlipidemia].
    Ota Y; Gotoda T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():424-9. PubMed ID: 12430264
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL-c is a powerful lipid predictor of cardiovascular diseases.
    Bruckert E; Hansel B
    Int J Clin Pract; 2007 Nov; 61(11):1905-13. PubMed ID: 17655681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR methodology applied to genetic studies of lipoprotein metabolism and atherosclerosis.
    Cole SA; Hixson JE
    Methods Mol Biol; 1998; 110():1-34. PubMed ID: 9918036
    [No Abstract]   [Full Text] [Related]  

  • 10. Is LPL deficiency atherogenic?
    Ebara T; Murase T; Okubo M
    Circ Res; 2008 Jun; 102(11):e118; author reply e119. PubMed ID: 18535262
    [No Abstract]   [Full Text] [Related]  

  • 11. The concentration of lipids, lipoproteins and apolipoproteins in cord blood serum of newborns in the course of intrauterine period.
    Pac-Kozuchowska E
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):25-32. PubMed ID: 15323161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role and mechanism of action of hepatic lipase].
    Piskorska D; Kopieczna-Grzebieniak E
    Przegl Lek; 1990; 47(9):648-50. PubMed ID: 2287752
    [No Abstract]   [Full Text] [Related]  

  • 13. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.
    Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
    Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B gene polymorphisms in people in the east Mediterranean area of Turkey.
    Tamer L; Tanriverdi K; Ercan B; Unlu A; Sucu N; Pekdemir H; Atik U
    East Mediterr Health J; 2004; 10(1-2):125-30. PubMed ID: 16201717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of lipoprotein metabolism. A new era].
    Masana Marín L
    Rev Clin Esp; 1990 Mar; 186(4):149-50. PubMed ID: 2367714
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis.
    Dergunov AD; Visvikis-Siest S; Siest G
    Vascul Pharmacol; 2008; 48(2-3):70-5. PubMed ID: 18221919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease.
    Hansen AS; Marckmann P; Dragsted LO; Finné Nielsen IL; Nielsen SE; Grønbaek M
    Eur J Clin Nutr; 2005 Mar; 59(3):449-55. PubMed ID: 15674304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.